News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Paggiarino Dario A.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2023 |
4
| Paggiarino Dario A. (Chief Medical Officer) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Granted 91,655 options to buy
@ $3.26, valued at
$298.8k
|
|
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2020 |
4
| Paggiarino Dario A. (Chief Medical Officer) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 4,168 shares
@ $0.8256, valued at
$3.4k
Exercised 14,200 restricted stock units
@ $0 |
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/15/2019 |
4
| Paggiarino Dario A. (Chief Medical Officer) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 2,450 shares
@ $2.105, valued at
$5.2k
|
|
| 06/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2019 |
4
| Paggiarino Dario A. (Chief Medical Officer) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 4,175 shares
@ $1.53, valued at
$6.4k
Exercised 14,200 restricted stock units
@ $0 |
|
| 03/21/2019 |
4
| Paggiarino Dario A. (Chief Medical Officer) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 1,188 shares
@ $2.47, valued at
$2.9k
|
|
| 10/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2018 |
4
| Paggiarino Dario A. (Chief Medical Officer) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 2,945 shares
@ $1.86, valued at
$5.5k
Exercised 10,000 restricted stock units
@ $0 |
|
| 06/18/2018 |
4
| Paggiarino Dario A. (Chief Medical Officer) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Granted 42,600 restricted stock units
@ $0
Granted 170,500 options to buy
@ $2.04, valued at
$347.8k
|
|
| 03/21/2018 |
4
| Paggiarino Dario A. (Chief Medical Officer) has filed a Form 4 on pSivida Corp.|
Txns:
| Granted 8,333 shares
@ $0 |
|
| 06/29/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/03/2016 |
4
| Paggiarino Dario A. (Chief Medical Officer) has filed a Form 4 on pSivida Corp.|
Txns:
| Granted 230,000 options to buy
@ $3.93, valued at
$903.9k
|
|
| 08/03/2016 |
3
| Paggiarino Dario A. (Chief Medical Officer) has filed a Form 3 on pSivida Corp. |
| 02/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/27/2013 |
4
| Paggiarino Dario A. (Sr VP & Chief Dev. Officer) has filed a Form 4 on LPATH, INC|
Txns:
| Granted 100,000 restricted stock units
@ $0 |
|
| 04/22/2013 |
3
| Paggiarino Dario A. (Sr VP & Chief Dev Officer) has filed a Form 3 on LPATH, INC |
|
|